US20230017481A1 - Treatment For Hydrocephalus - Google Patents
Treatment For Hydrocephalus Download PDFInfo
- Publication number
- US20230017481A1 US20230017481A1 US17/935,882 US202217935882A US2023017481A1 US 20230017481 A1 US20230017481 A1 US 20230017481A1 US 202217935882 A US202217935882 A US 202217935882A US 2023017481 A1 US2023017481 A1 US 2023017481A1
- Authority
- US
- United States
- Prior art keywords
- slits
- cerebrospinal fluid
- csf
- coating
- ventricular catheter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000003906 hydrocephalus Diseases 0.000 title description 10
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims abstract description 180
- 238000009825 accumulation Methods 0.000 claims abstract description 7
- 230000002861 ventricular Effects 0.000 claims description 95
- 238000000576 coating method Methods 0.000 claims description 39
- 239000011248 coating agent Substances 0.000 claims description 33
- 229920006149 polyester-amide block copolymer Polymers 0.000 claims description 3
- 238000001179 sorption measurement Methods 0.000 claims description 3
- 102000004506 Blood Proteins Human genes 0.000 claims description 2
- 108010017384 Blood Proteins Proteins 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 claims description 2
- HFCUBKYHMMPGBY-UHFFFAOYSA-N 2-methoxyethyl prop-2-enoate Chemical compound COCCOC(=O)C=C HFCUBKYHMMPGBY-UHFFFAOYSA-N 0.000 claims 1
- 230000007246 mechanism Effects 0.000 description 45
- 238000004140 cleaning Methods 0.000 description 43
- 210000004556 brain Anatomy 0.000 description 31
- 239000000463 material Substances 0.000 description 19
- 238000000034 method Methods 0.000 description 16
- 230000033001 locomotion Effects 0.000 description 9
- 238000004891 communication Methods 0.000 description 8
- 210000001015 abdomen Anatomy 0.000 description 7
- 239000000017 hydrogel Substances 0.000 description 7
- 210000003200 peritoneal cavity Anatomy 0.000 description 6
- 238000013459 approach Methods 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- -1 Poly(2-methoxyethylacrylate) Polymers 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000007917 intracranial administration Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 235000015816 nutrient absorption Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000000541 pulsatile effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000005166 vasculature Anatomy 0.000 description 2
- 206010006126 Brain herniation Diseases 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- YBDACTXVEXNYOU-UHFFFAOYSA-N C(F)(F)(F)F.[Li] Chemical compound C(F)(F)(F)F.[Li] YBDACTXVEXNYOU-UHFFFAOYSA-N 0.000 description 1
- 208000004434 Calcinosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010073706 Cerebral ventricle collapse Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- JFZHPFOXAAIUMB-UHFFFAOYSA-N Phenylethylmalonamide Chemical compound CCC(C(N)=O)(C(N)=O)C1=CC=CC=C1 JFZHPFOXAAIUMB-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000001782 Slit Ventricle Syndrome Diseases 0.000 description 1
- 208000002667 Subdural Hematoma Diseases 0.000 description 1
- DTJAVSFDAWLDHQ-UHFFFAOYSA-N [Cr].[Co].[Pt] Chemical compound [Cr].[Co].[Pt] DTJAVSFDAWLDHQ-UHFFFAOYSA-N 0.000 description 1
- YFXWODPYUNGUEE-UHFFFAOYSA-N [I].[Li] Chemical compound [I].[Li] YFXWODPYUNGUEE-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229910052790 beryllium Inorganic materials 0.000 description 1
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 210000003096 cerebellopontine angle Anatomy 0.000 description 1
- 210000002987 choroid plexus Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001483 poly(ethyl methacrylate) polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/148—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
- A61M27/006—Cerebrospinal drainage; Accessories therefor, e.g. valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0019—Cleaning catheters or the like, e.g. for reuse of the device, for avoiding replacement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0238—General characteristics of the apparatus characterised by a particular materials the material being a coating or protective layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3341—Pressure; Flow stabilising pressure or flow to avoid excessive variation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0693—Brain, cerebrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/12—Blood circulatory system
- A61M2210/125—Heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
Definitions
- Cerebrospinal Fluid is a fluid found in the brain and spinal cord.
- CSF is produced in the choroid plexus of the ventricles of the brain and serves several purposes—including acting as a cushion for the brain, acting as a mechanism for delivering nutrients from and removing waste from the brain, and regulating changes in pressure within the brain.
- CSF production exceeds its absorption, the pressure from CSF rises which can lead to an abundance of CSF—this in turn can result in hydrocephalus, which is swelling of the brain due to buildup of CSF.
- Hydrocephalus can cause balance and vision issues, increased head size, bleeding in the brain, cerebral edema, impaired brain function, brain herniation, as well as other issues.
- shunting which involves routing the CSF from the brain to another region of the body, such as the abdomen, lung, or heart.
- One popular routing area is the peritoneal cavity in the abdomen; routing from the brain ventricles to the peritoneal cavity is known as Ventriculoperitoneal (VP) shunting.
- the shunt system utilizes a ventricular catheter in the brain to collect and route the CSF, a second drainage catheter to redirect the CSF to another region of the body (e.g., the peritoneal cavity), and a valve in between to regulate flow of CSF from the brain to the drainage region.
- the present invention relates to devices, systems, and methods designed to address issues with the shunting procedure.
- a shunting system includes a cleaning mechanism designed to clean residue from CSF in the ventricular catheter of a broader shunting system.
- the cleaning mechanism includes a spring plunging element used to clean slits that allow CSF passage.
- the cleaning mechanism includes a cleaning piston element used to clean slits allowing CSF passage.
- the cleaning mechanism includes a rotational element used to clean slits allowing CSF passage.
- a ventricular catheter used in a CSF draining shunt system includes slits to facilitate CSF drainage and biodegradable or bioresorbable material along one or more of these slits.
- a locking mechanism facilitating secure fitting between a catheter tubing and a shunt valve element is described.
- a mechanical valve utilizing a weighted or thinned disc portion is described.
- the mechanical valve regulates CSF flow within a valve housing, between a CSF inlet and CSF outlet.
- a hydrogel is utilized to seal a hole opening used to gain vascular access during the CSF shunting procedure.
- an electrical system used to monitor and/or communicate patient data associated with a CSF shunt system is described.
- the shunt system includes a mechanical, electromechanical, and/or an electrical mechanism to selectively regulate CSF flow.
- FIG. 1 illustrates a shunt system
- FIG. 2 illustrates a ventricular catheter with a plurality of slits allowing entry of CSF.
- FIG. 3 illustrates a spring-plunger cleaning mechanism in an extended configuration used with a ventricular catheter, according to one embodiment.
- FIG. 4 illustrates a spring-plunger cleaning mechanism in a retracted configuration used with a ventricular catheter, according to one embodiment.
- FIG. 5 illustrates a closer view of the spring-plunger cleaning mechanism of FIG. 3 in an extended configuration.
- FIG. 6 illustrates a closer view of the spring-plunger cleaning mechanism of FIG. 4 in a retracted configuration.
- FIG. 7 illustrates a fixed piece of a spring-plunger cleaning mechanism, according to one embodiment.
- FIG. 8 illustrates a movable piece of a spring-plunger cleaning mechanism, according to one embodiment.
- FIG. 9 illustrates an inner lumen of a movable piece of a spring-plunger cleaning mechanism, according to one embodiment.
- FIG. 10 illustrates an inner lumen of a movable piece of a spring-plunger cleaning mechanism, according to one embodiment.
- FIG. 11 illustrates a ventricular catheter utilizing a plurality of small CSF entry slits usable with a cleaning mechanism, according to one embodiment.
- FIG. 12 illustrates a cleaning mechanism utilizing a spring and piston in an extended configuration, according to one embodiment.
- FIG. 13 illustrates a cleaning mechanism utilizing a spring and piston in a contracted configuration, according to one embodiment.
- FIG. 14 illustrates a ventricular catheter utilizing a plurality of small slits which can be used with a cleaning mechanism, according to one embodiment.
- FIG. 15 illustrates a shunt valve interface
- FIG. 16 illustrates a locking mechanism for a shunt valve interface, according to one embodiment.
- FIG. 17 illustrates a shunt valve system, according to one embodiment.
- FIG. 18 illustrates the valve used in the shunt valve system of FIG. 17 , according to one embodiment.
- FIG. 19 illustrates a top disc used in a valve, according to one embodiment.
- FIG. 20 illustrates a bottom disc used in a valve, according to one embodiment.
- FIG. 21 illustrates a flowchart for an electrical communication system used as part of a shunt system, according to one embodiment.
- the shunt system can redirect the CSF to various areas of the body including lungs, heart, or other regions of the brain.
- VP shunting involving redirection of the CSF to the peritoneal cavity in the abdomen, is one popular shunting technique.
- the shunting systems, devices, techniques, and methods described in the inventive embodiments herein will often be described for us with VP shunts (that is, shunting systems routing CSF to the abdominal section), it can also be used in shunt systems redirecting CSF elsewhere in the body/vasculature.
- FIG. 1 shows the broad overview of a VP shunt system 100 .
- the shunt acts to move CSF from the brain 102 to the abdominal peritoneal cavity 110 .
- the shunt system includes a collection or ventricular catheter 104 collecting CSF in the ventricles of the brain and conveying CSF away from the ventricles of brain 102 .
- the system further includes a secondary exit or drainage catheter 108 to direct the collected CSF into the peritoneal cavity 110 of the abdomen.
- a valve 106 regulating flow between the two catheters is between the two catheters 104 , 108 .
- the valve's purpose is to regulate how much CSF is conveyed from the brain (via ventricular catheter 104 ) to the abdomen (via drainage catheter 108 ).
- the valve 106 can include a number of mechanical/electrical valve mechanisms commonly known in the art to regulate the flow.
- Shunting has relatively high failure rates, there are an estimated 18,000-33,000 shunts placed each year in the US however up to 1 ⁇ 3 of these fail within the first year and up to 50% fail within the first two years.
- the causes of failure are numerous, including mechanical failure with the flow valve which drains CSF, and material buildup in the catheters which causes blockages.
- the CSF has proteins or calcium and these materials can build up in the catheters, leading to clogging of the catheter draining system.
- This problem is more pronounced in the ventricular catheter which acts as the entry point for the brain CSF to enter the shunt system, and which therefore is exposed to more CSF. Over time, this can lessen how effective shunting is to redirect CSF as the catheter gets filled with more material buildup. Over time this may necessitate the implantation of a new ventricular catheter or an entirely new shunting system.
- the ventricular catheter 104 is shown in more detail in FIG. 2 .
- the ventricular catheter 104 typically includes a number of holes or slits 114 spaced along the end section of the catheter (i.e., the portion of the ventricular catheter 104 which is farthest relative to valve 106 , which is the portion of the ventricular catheter 104 which will be exposed to CSF in the ventricles). These holes or slits 114 act as entry conduits for the CSF to enter the ventricular catheter 104 . A number of spaced holes/slits are preferred so there are ample points of entry for the CSF to enter the catheter, thereby maximizing the drainage potential. Though four holes/slits 114 are shown in FIG.
- slits or holes being located along various portions of the ventricular catheter 104 .
- These holes or slits 114 are often where the matter buildup from CSF (e.g., protein or calcium deposits) tends to accumulate. Over time as the material builds up in these entry ports, less and less CSF is able to enter the ventricular catheter—in turn inhibiting the ability of the shunt system to function effectively to drain CSF.
- CSF e.g., protein or calcium deposits
- FIGS. 3 - 4 illustrate one embodiment of a cleaning mechanism 120 used to clean the CSF entry slits 114 of ventricular catheter 104 .
- the mechanism 120 is built over a section of the ventricular catheter 104 and sits over the CSF entry holes 114 .
- Cleaning mechanism 120 utilizes a reciprocating approach to clean the entry slits 114 , wherein the mechanism has a first expanded position where it covers the slit and a second contracted position where the slits is exposed.
- one mechanism 120 is used for each slit of the ventricular catheter.
- each mechanism 120 covers a plurality of slits so that a plurality of slits are cleaned with each cleaning mechanism 120 .
- cleaning mechanism 120 utilizes a spring plunger as the basis of the reciprocating motion—shown in more detail in FIGS. 5 - 6 .
- Cleaning mechanism 120 utilizes a spring plunger system which includes a fixed base piece 122 and movable reciprocating piece 132 .
- the fixed base piece 122 has a platform 124 , with one or more springs 126 connected to the platform.
- One end of spring(s) 126 is connected to the platform 124 while the other end of spring(s) 126 is connected to the reciprocating piece 132 .
- the reciprocating piece is hollow in that it is not completely solid—preferably this involves the use of a thin outer wall and a thin inner wall, where the springs are located between these two wall sections.
- Base piece 122 and reciprocating piece 126 each include an inner lumen, this lumen is necessary so that the entire cleaning mechanism 120 can slide over the ventricular catheter; therefore, the inner lumen of the base piece 122 and the inner lumen of the reciprocating piece 132 will be larger than the outer diameter of the ventricular catheter 104 .
- These lumens are shown in more detail in FIGS. 7 - 8 , where fixed piece 122 includes an inner lumen 122 a which is sized larger than the ventricular catheter outer diameter and movable piece 132 also includes an inner lumen 132 a sized larger than the ventricular catheter outer diameter.
- spring(s) 126 are contemplated, in one embodiment, a plurality of springs 126 are used which are spaced in equivalent circumferential intervals along the inner part of the movable piece 132 .
- the reciprocating piece When springs 126 are fully elongated, the reciprocating piece will be located in its farthest position relative to the base piece, as shown in FIGS. 3 and 5 ; this corresponds to the reciprocating piece 132 covering an associated slit 114 .
- the springs 126 When the springs 126 are fully compressed, the reciprocating piece will retract relative to the base piece, as shown in FIGS. 4 and 6 ; this corresponds to the reciprocating piece 132 exposing an associated slit 114 thereby facilitating easier entry of CSF into the associated slit/hole 114 .
- FIG. 7 shows the base piece 122 , which includes the inner lumen 122 a which allows the piece to be mounted over the ventricular catheter. Inner lumen 122 a should therefore be a larger size than the ventricular catheter so that it can be placed over it, as described above.
- the fixed/base piece 122 also includes a platform 124 which the one or more springs 126 are attached to, as discussed above.
- FIG. 8 shows movable/reciprocating piece 132 in more detail.
- the movable piece 132 is movable relative to both the ventricular catheter 104 and the fixed piece 122 .
- Movable piece 132 includes its own lumen 132 a so that it can be placed over the ventricular catheter and is therefore sized larger than the ventricular catheter, as described above.
- This lumen 132 a is preferably sized larger than fixed piece 132 so that the movable piece 132 can slide over fixed piece 122 , in the manner shown in FIGS. 4 and 6 when the springs are compressed.
- Movable piece 132 is hollow in that there is a first outer wall defining the outer perimeter of the movable piece 132 , a second wall defining the inner lumen 132 a , and open space in between.
- the springs 126 span this open space channel section and are attached to the interior of the movable piece 132 .
- the other end of spring(s) 126 is attached to the platform section of fixed base piece 122 , as described earlier. While base piece 122 is mechanically fixed to the ventricular catheter surface (e.g., through a connection medium such as adhesive, welds, or other means between the base piece inner lumen 122 a and the underlying ventricular catheter), the movable piece 132 is not fixed and in this manner it reciprocates to adopt the positions shown in FIGS.
- the one or more springs 126 connecting the base piece 122 to reciprocating/moving piece 132 will compress and elongate along with the pressure of the region, which will vary based on blood flow due to the pumping of the heart. Therefore, there should be a relatively consistent cycle of elongation and compression that tracks to the heartbeat and natural flow of blood through the vasculature that results. In this manner, batteries, motors, or other external drivers will not be needed to control the position of movable piece 132 , although certain embodiments may utilize these additional elements to electromechanically control the position of movable piece 132 .
- the wall forming the circumference of inner lumen 132 a can include one or more projecting structures that project radially inward within lumen 132 a . In this manner, the projecting structures would either graze or physically enter into a portion of the slits 114 as the movable piece 132 passes over the slits, thereby cleaning them.
- the wall can include a roughened or abrasive surface which projects slightly into lumen 132 a , and which would graze or project slightly into the slits as the movable piece passes over the slits.
- one or more brushes are utilized which project from inner lumen 132 a .
- a projecting element such as a bar
- roughened/abrasive elements or brush-like elements 134 are shown as extending from within the interior of the inner lumen 134 of the movable piece 132 .
- These cleaning elements 132 , 134 could either extend directly from the wall of the inner lumen 132 a or could extend from the interior of the movable piece 132 and pass through into the inner lumen 132 a.
- the projections or roughened surfaces may have to be particularly lengthy in order to contact the holes of the ventricular catheter.
- One way to mitigate this is to include another smaller internal secondary lumen on movable piece 132 , which functions to also fit over the ventricular catheter. Including the smaller secondary lumen will minimize the gap between the ventricular catheter, and including the projections or roughened regions utilized in this smaller secondary lumen will mean the projections/roughened sections can be smaller and still contact the holes or slits to clean them.
- the slits only sit on one side of the catheter, and the inner lumen has projections, abrasions, brushes, or the cleaning surface 134 sitting only along one face of the lumen, as shown in FIGS. 9 - 10 .
- the slits are along opposing sides of the catheter. The cleaning surface can then sit along both sides of the lumen to clean the slits on either end.
- the cleaning surfaces of the inner lumen 132 a of movable piece 132 are radially and/or longitudinally spaced throughout all or a portion of the inner lumen 132 a (therefore, located in various areas of the inner lumen 132 a ).
- a plurality of slits 114 are used along the ventricular catheter 104 and some or all of these slits are configured such that each slit utilizes its own individual cleaning mechanism 120 (as shown in FIG. 4 ).
- a plurality of cleaning mechanisms 120 are used and the movable pieces 132 are connected to each other (e.g. via springs). In this way the motion of some or all of the movable pieces 132 on different cleaning mechanisms 120 can be coordinated together whereby the movable pieces 132 will extend in unison and retract in unison (and not solely relying on the pulsatile nature of blood flow).
- an external electromechanical driver is used to drive the movement of movable piece 132 , these cycles can be coordinated through a common driver or through a plurality of drivers that are synced together.
- the ventricular catheter 104 may utilize a number of tiny slits 144 , rather than utilizing larger slits 114 that are sized so that a single cleaning mechanism can be used for each slit.
- a single spring plunger cleaning mechanism 120 as described and shown above in FIGS. 3 - 10 can be utilized to clean a plurality of these slits.
- one cleaning mechanism 120 will span the plurality of slits shown in FIG. 11 .
- the plurality of cleaning surfaces 134 of the inner lumen 132 a of the movable piece 130 will be used to clean a number of the smaller slits 144 .
- one cleaning mechanism 120 can be used to clean a plurality (or all) of the slits 144 .
- the slits are spaced out over the ventricular catheter in different segments and each segment utilizes its own cleaning mechanism 120 to clean the plurality of slits in that particular catheter segment.
- the movable pieces can optionally be linked as described above so that the movable pieces move in unison, or otherwise no linking is used and the pulsatile nature of blood controls the movement of the movable pieces (which should generally cause a relatively consistent movement pattern across all the movable pieces).
- FIGS. 12 - 13 Another embodiment of a cleaning mechanism is shown in FIGS. 12 - 13 .
- This embodiment utilizes a housing 140 that overlaps an end section of a ventricular catheter 104 (e.g., the section of the ventricular catheter containing CSF entry holes or slits 114 ).
- the inside of the housing 140 contains a piston cleaning element 146 with a thickened end region 148 , and a spring 150 connected to the piston such that the piston can reciprocate between a proximally oriented configuration and a distally oriented configuration, as shown in FIGS. 12 - 13 .
- the spring extends and compresses based on various variables. In one example, as CSF collects in the housing, it exerts pressure against the piston 146 and connected spring 150 .
- the piston has an inner lumen which is sized slightly larger than the ventricular catheter end section, and in this way the piston 146 (as well as housing 140 and spring 150 ) sit around the ventricular catheter.
- the inner lumen utilizes the various projections, brushes, or roughened surfaces discussed earlier with regard to the embodiments shown and discussed in FIGS. 3 - 10 (particularly highlighted in FIGS.
- the thickened end region 148 of the piston slightly contacts the housing and functions to clean the interior surface of the housing from the CSF buildup.
- This end region 148 can contain a similar projection, brush, or abrasive interface to help clean or scrape the buildup from the interior of the housing 140 .
- This housing element 140 is preferably placed on the very end section of the ventricular catheter where the CSF accumulates in the neurovasculature, in one example this end catheter section would sit within the cerebellopontine angle cistern section of the neurovasculature.
- One advantage of the cleaning interface of FIGS. 12 - 13 is that the CSF drainage is metered since as the CSF accumulates, it exerts pressure on the piston 146 and spring 150 . As this pressure increases, it pushes the piston and spring toward the configuration of FIG. 13 exposing more holes 114 as the pressure mounts, thereby increasing the CSF drainage as the pressure increases.
- Over drainage of CSF is problematic since a certain amount of CSF is needed in the brain to cushion the brain and to help promote proper nutrient absorption. Under-drainage of CSF is bad since this will then cause too much CSF to accumulate leading to increased pressure on the brain and hydrocephalus.
- the CSF drainage is controlled based on the accumulated pressure exerted by the CSF, so some CSF is allowed to accumulate but excess CSF will cause drainage as the pressure builds-up owing to the piston/spring interface.
- the spring tension and piston weight can be customized to precisely control the amount of CSF drainage allowed.
- an electrically integrated system is utilized where the spring tension is mechanically customized and altered based on passive measurements taken by an integrated electrical-based measuring system so that the proper drainage is customized based on a measurement system measuring CSF pressure (of the pressure CSF is exerting against the piston 148 and/or spring 150 ).
- a rotating element is connected to a mechanical rod within the housing 140 and this rotating element circulates within the interior of the housing cleaning the holes 114 .
- the rotating element would be located circumferentially around the ventricular catheter 104 between in the space between the catheter and the housing.
- the rotating element is a disc (with a lumen larger than the ventricular catheter 104 so as to be placed around said catheter) and can utilize various projections or brushes to clean the slits/holes 114 .
- the disc moves proximally and distally utilizing a connected spring-element, similar to the embodiments of FIGS. 12 - 13 .
- one or more discs are used which span a plurality of holes lengthwise along the catheter 104 .
- no external housing 140 is used—instead, the internal section of the catheter 104 utilizes an end rotating disc element which rotates to clean the various slits 114 .
- the disc is capable of proximal and distal movement, for instance via connection to an end spring similar to the spring 150 of FIGS. 12 - 13 .
- FIG. 1 Another embodiment of the present invention can address the issue of CSF and associated matter accumulation along the ventricular catheter fluid entry locations by utilizing particular coatings on the ventricular catheter surface of the section of the ventricular catheter containing CSF entry holes 114 .
- These coatings can either be in addition to the cleaning mechanism concepts discussed above or can be used as a stand-alone solution.
- the ventricular catheter or entry holes 114 can be coated with a plasma protein adsorption suppressant, such as, but not limited to, Poly(2-methoxyethylacrylate) (PEMA or X-Coat).
- PEMA Poly(2-methoxyethylacrylate)
- X-Coat Antibacterial coating can also be used to prevent infection.
- the entry holes 114 and catheter inner lumen can also be customized to help prevent clogging and obstruction from CSF buildup, for instance larger entry holes and a larger inner lumen can be used to help prevent clogging.
- the inner wall of the ventricular catheter 104 can also utilize these coatings to prevent material buildup within the catheter itself.
- Other embodiments can utilize a biodegradable or bioresorbable material to cover CSF entry holes 114 , whereby the material will degrade or resorb over different time periods to expose the holes.
- the idea here is that as some holes not utilizing this material get clogged with CSF over time, other holes with degradable or resorbable covering material (which disappears or degrades over time) will then open up allowing CSF to drain through these other holes.
- the ventricular catheter will be manufactured with extra holes or slits 114 .
- a thin film of biodegradable or bioresorbable material such as, but not limited to, polyalpha-hydroxy-acids and/or polyesteramide (PEA), that will take a set amount of time to resorb.
- PPA polyalpha-hydroxy-acids and/or polyesteramide
- Materials with multiple/different resorption rates can be used to cover various holes; this difference in resorption rate can be due to a thicker vs thinner amount of covering material, or alternatively due to different materials being used which have different resorption rates.
- a layer of coating can be applied on the catheter (and/or the flow control valve connected to the ventricular catheter to selectively allow the CSF to drain out of the drainage catheter into the abdomen) to further prevent protein adsorption.
- holes 114 a are designed as completely open (meaning, without a coating) so these holes will be the initial ones CSF will flow into (but may also clog over time).
- Holes 114 b utilize a membrane which resorbs after, for example, 12-24 months—meaning these holes will fully open at 12-24 months which will help account for the portion of holes 114 a which get clogged.
- Holes 114 c can then utilize a membrane covering which resorbs at about 3-4 years, which will help account for the portion of holes 114 a - 114 b that get clogged. This pattern can continue with various hole segments along the length of the ventricular catheter 104 .
- holes with different resorption rates can also be spaced in different locations along the catheter to produce a more randomized profile. In this way, as certain holes get clogged, others will open and there is less likelihood of a majority or a plurality of holes all clogging at around the same time (which would undesirably decrease the CSF drainage effectiveness). This approach decreases the chance that a new ventricular catheter will have to be implanted, or at least spaces out the intervals where this procedure will have to be undertaken.
- One additional advantage of this approach is that a calibrated CSF drainage protocol is maintained. While some holes get clogged over time thereby decreasing their CSF entry/drainage potential, others newly open thereby roughly balancing the total amount of holes/slits available at any given time to evacuate CSF.
- the coatings can be applied in various locations, including along the slits/holes/openings 114 of the ventricular catheter, as described. In one embodiment the coating projects outwardly from the holes. In one embodiment the coating is applied such that it projects radially inward from the holes. In one embodiment the coating is flush with the plane of the hole itself.
- the coating can be applied in a variety of manners including through a mechanical (hand) coating process, or by machine. In one embodiment, the entire catheter (or a portion of the catheter) itself is dipped in the coating solution where the coating is equally applied through the dipped section of the catheter. In some embodiments, the drainage catheter also utilizes the coating in order to prevent bacterial or material buildup. In some embodiments, the coating is utilized along the section of the catheter immediately adjoining the valve so prevent material buildup from interfering with the mechanical valve apparatus.
- FIG. 15 shows a typical shunt connective interface.
- the typical system includes a shunt housing/valve 200 which includes a valve element to selectively meter CSF.
- a first 202 and second 204 connective interface/fitting which connect respectively to a ventricular catheter (a first end of which is in the CSF accumulation region of the brain, and a second end of which is attached to the connective interface 202 ) and a drainage catheter (a first end of which is attached to the connective interface 204 and a second end of which routes to the drainage region, e.g. the abdomen).
- the typical interface includes a ridge 202 a and 204 a that the catheter is placed over to enable a snug connection between the catheter and the shunt valve.
- this section does not necessarily secure the catheter and the catheter can often become detached from the fitting and the connective interface.
- FIG. 16 shows an embodiment of a connective interface or fitting 206 (this fitting can represent one or either of the two fittings 202 , 204 which are at either end of the shunt valve housing 200 ) utilizing a plurality of connection elements 206 a .
- These elements are female depressions or recessions that extend into the surface of the fitting 206 , male projections that extend outwardly from the surface of the fitting 206 , or some combination of the two.
- the end section of the catheter in particular, the section of the catheter that is placed over the fitting—contains a corresponding interface (e.g., a projection that mates with the depression of the fitting 206 , a depression that mates with the corresponding projection of the fitting 206 , etc.) such that the catheter and fitting are bound by the mating between the respective interfaces.
- a corresponding interface e.g., a projection that mates with the depression of the fitting 206 , a depression that mates with the corresponding projection of the fitting 206 , etc.
- a portion, or all of the connection elements 206 a can be used whereby the catheter can utilize its own corresponding mating interface that links with a portion or all of the connection elements 206 a .
- connection elements 206 a can be considered as projections that extend outwardly from the fitting 206
- the whitened connection elements 206 a can be considered as recesses that inwardly recede from the fitting 206 .
- the corresponding interface surface on the end of the connecting catheter will then have corresponding surfaces to mate with this region (e.g., a recessed or female area to mate with blackened projection 206 a , and a male projection to mate with whitened female recess 206 a ).
- Not all of the connection elements 206 a have to be engaged.
- a portion of the connection elements 206 a are actually used to bind the fitting to the overlying catheter.
- only projections or only recessed sections are used.
- the fitting interface 206 a utilizes only female depressed structures and the catheter interface comprises only male projecting structures—alternatively, the fitting interface 206 a is only male projection structures and the catheter interface comprises only female recessed structures.
- Typical shunt valves utilize a one-way valve design comprising a ruby ball that presses against a spring, where the valve opens up once a certain pressure is reached to allow CSF passage through the valve outlet section and into the drainage catheter.
- magnets are further used to optimize the desired CSF flow rate for each patient.
- mechanical failure of valve components is common. The following embodiments discuss a valve concept utilizing fewer mechanical parts to address this valve failure issue.
- a shunt valve housing 200 is shown in FIG. 17 , including an inlet end 202 connected to a ventricular catheter which collects CSF and an outlet end 204 connected to a drainage catheter which drains CSF.
- Valve housing 200 includes a pre-chamber 208 and a valve chamber 209 containing a valve 210 , where CSF initially follows into the pre-chamber 208 and then into the valve chamber 209 .
- the valve chamber 209 contains a top section 209 a and a bottom section 209 b , and a valve 210 in between the two sections modulating flow therebetween.
- Valve 210 is shown in more detail in FIG. 18 and includes a stem 214 and a protruding anchor 212 where the anchor is anchored to the top section of valve chamber 209 through a hole. There are inlet holes 211 around the anchor allowing inflow of CSF as shown in FIG. 17 .
- Valve 210 includes a top disc 216 and a bottom disc 218 ; both discs are respectively shown in more detail in FIGS. 19 - 20 and contain a middle hole allowing passage of the valve stem 214 whereby the valve stem 214 binds the two discs together.
- the mechanical valve operation which is how the valve 210 opens and closes, will now be explained in more detail.
- the valve 210 comprises a top disc 216 and a bottom disc 218 , as described above.
- Top disc 216 contains a number of holes 220 which are aligned with the inlet holes 211 of the valve chamber 209 . Once CSF enters the valve chamber 209 , it will flow through inlet holes 211 and into the holes 220 of the top disc 216 .
- the bottom disc 218 does not have such a plurality of holes, instead it is weighted such that the a portion of the bottom disc 218 (e.g., the right side of the disc which is the portion which faces the outlet 204 ) is lighter than the other portion (e.g., the left side).
- This variable weighting can be accomplished in a number of ways—such as by using lighter material on the lighter portion of the bottom disc 218 , or by making a portion of the bottom disc thinner.
- the CSF weight and pressure increases as it accumulates into the top section of the valve chamber 209 and enters the holes of the top disc 216 , the weight will increase whereby the lighter section of the bottom disc 218 will eventually pivot allowing the CSF to exit.
- This pivoting action means that the stem section 214 is either slightly longer than the bottom disc or is not fixed directly to the bottom disc 218 , meaning the bottom disc 218 has some give and has some slight degree of movement as the CSF weight increases.
- valve 210 has a closed configuration when the CSF threshold weight is not surpassed where the top and bottom discs are snug so that CSF cannot exit the valve.
- the valve 210 next has a partially open configured where the thinner or lighter portion of the bottom disc 218 (e.g., the section of the disc which is closer to the outlet end 204 of the shunt valve system) opens to allow partial CSF outflow.
- the valve 210 has a fully opened configuration where the entire bottom disc 208 opens or pivots with respect to the top disc allowing maximum drainage of CSF.
- the valve's 210 discs 216 , 218 are both silicone and approximately 0.3 inches in diameter.
- the top disc 216 is about 0.07′′ thick and contains 6-8 holes 220 around the perimeter.
- Bottom disc 218 decreases in thickness as it moves around the disc circumference, as discussed above, where the thickest section is about 0.07′′ and the thinnest section is about 0.02′′. Though the earlier description specifically discussed the portion of the bottom disc 218 facing the outlet 204 as the thinnest, in practicality it would not necessarily matter which section of bottom disc 218 is thinner since the CSF will likely accumulate in the bottom chamber 209 b of the valve chamber 209 and then be pushed through the outlet 204 once the bottom chamber fills with CSF.
- pre-chamber 208 The purpose of pre-chamber 208 is to accumulate CSF prior to it entering the valve chamber 209 .
- the pre-chamber 208 can also be used for hypodermic sampling of CSF, and/or can used to test for proper valve function.
- the pre-chamber can be pressed down or palpated/palpitated for testing purposes.
- the valve flow can be configured so a certain amount of fluid always stays in the pre-chamber while not enough fluid stays in the pre-chamber so as to completely fill it. If the pre-chamber bubble cannot be pressed down, it will indicate distal catheter obstruction since the pre-chamber will be completely filled.
- the pre-chamber bubble stays down after being pressurized, it would indicate proximal catheter obstruction—therefore the pre-chamber material characteristics can be configured to act as an indicator of proper functionality of the ventricular (brain) catheter and the drainage (abdominal) catheter.
- Hydrogels are a class of compounds that expand or swell in response on a particular stimulus. Hydrogels for vascular therapeutic purposes are often designed to expand based on contact with aqueous material (e.g., the aqueous portion of blood) or based on pH (e.g., the pH of blood).
- hydrogels such as but not limited to polyethylene glycol or polytetramethylene oxide can be applied to the area to help seal the created opening.
- a portion of the distal tip of the ventricular catheter (meaning the end portion of the ventricular catheter within the neurovasculature CSF accumulation point) utilizes hydrogel, such as the portion that is about 5 centimeters away from the distal tip, to help seal the opening.
- the hydrogel can be applied using a syringe after the catheter is placed in position within the ventricles of the neurovasculature.
- a vein such as the inferior petrosal sinus may be punctured to place the valve.
- the hydrogel can be applied to the tip of the shunt where the shunt is anchored into the vessel wall to seal the puncture and to help keep the shunt firmly in place.
- ICP intracranial pressure
- the pressure sensor which is included in the flowchart of FIG. 21 is used to monitor ICP and in one embodiment uses a micro-electromechanical (MEMS) silicon-based pressure sensor.
- MEMS micro-electromechanical
- the silicon-based pressure sensor utilizes the proportional change of resistance elements located within the sensor.
- the pressure sensor could be placed anywhere within the shunt system, including within the ventricular catheter, valve housing, or drainage catheter—additionally various pressure sensing elements could be placed in different areas of the shunt system (e.g., one in the ventricular catheter and one in the valve housing) to create a broader ICP representation as well as help identify where any blockage is located.
- a separate pressure sensor can be implanted near the ventricular catheter so that the pressure represents the ICP physically within the ventricular region where the CSF accumulates.
- the flowchart also includes an antenna system used to convey data to a wireless enabled device (e.g., a watch, smartphone, computer, or tablet).
- a wireless enabled device e.g., a watch, smartphone, computer, or tablet.
- One embodiment for the antenna portion of the electrical system utilizes a non-magnetic conductive trace pattern (e.g., utilizing gold-plated copper, platinum, beryllium) which is designed into the surface of the shunt catheter and connected to the antenna interface circuitry.
- the conductive section links a measurement taking sensor (such as the pressure sensor) to the antenna to transmit the relevant data or links the controller which compiles the relevant data to the antenna for transmittal.
- the conductive pattern is designed to have optical radio frequency transmission characteristics over the selected wireless communication protocol (for instance, BLE frequencies of 2.4-2.4835 GHz).
- a ventricular anchor exits the CSF accumulation vein of the neurovasculature, and the catheter then is located within the vein, whereby the anchor serves to keep the ventricular catheter in place.
- This embodiment utilizes a ventricular anchor comprised of conductive material (e.g., stainless steel, platinum cobalt chromium, etc.) with geometry sized for the RF transmission characteristics of the frequencies required, where the anchor itself acts as the antenna or acts as the conductive electrical communication medium for the antenna.
- conductive material e.g., stainless steel, platinum cobalt chromium, etc.
- One embodiment utilizes an energy storage concept to utilizing a capacitive storage element embedded within the walls of the ventricular catheter.
- the capacitive storage element is constructed of two concentric tubes of different diameters, and the space between the two conductive tubes is filled with a dielectric material.
- the dielectric has a sufficient dielectric constant to provide large enough capacitance between the two tubes to store sufficient energy for the electrical system to operate.
- the capacitor is charged through an external charge source such as an inductively coupled charging station or energy harvesting (e.g., thermal, RF or piezo-electrical energy) controlled by the charge controller.
- the electrical system utilizes a hermetically sealed implantable battery utilizing a lithium-iodine or lithium-carbon fluoride battery.
- the electrical communications system described above and shown in FIG. 21 passively measures ICP to convey this information to an external device to relay this information to the user.
- the electrical system varies the valve characteristics (e.g. loosens or tightens the valve to either augment CSF discharge or reduce CSF discharge) based on measured ICP data.
- a certain amount of CSF is needed so the shunt valve cannot constantly drain CSF but instead typically drains CSF once a certain pressure is exceeded.
- this system utilizes a mechanical valve which mechanically opens or mechanically enables flow once a threshold pressure is exceeded. In certain circumstances it can be difficult to design an optimum valve since every patient is different (for instance, each patient will have different brain sizes, different CSF production amounts, etc.).
- the monitoring system itself can link to the valve and open or close the valve based on the calculated ICP to provide a customizable valve profile.
- the electrical system communicates with the valve and then opens the electro-mechanical valve.
- This threshold value can constantly be updated based on observed phenomena or can be calibrated based on a stored physician-enabled profile.
- This system can also be used to continuously monitor CSF and make continuous small adjustments valve to control how “open” the valve is to create a constantly updated valve profile where small adjustments in the valve opening profile are being made on a relatively continuous basis as needed.
- a master electrical communication system is used to monitor ICP. This system is then directly linked to the valve to adjust the valve to enable more CSF flow through the valve or limit CSF flow through the valve, as needed.
- CSF drainage rate changes when a person goes from a supine or flat position (e.g. when sleeping) to an upright position. Due to gravity, this movement change can cause CSF to suddenly drain since the drainage catheter goes from a horizontal position to a vertical position as the patient sits upright. However, this increase in drainage can be undesirable since it is in response to a change in patient orientation, rather than resulting from an accumulation of CSF.
- CSF over drainage is risky because too little CSF in the neurovasculature can cause ventricles to collapse, tearing of blood vessels, headaches, subdural hematoma, slit ventricle syndrome where the ventricles decrease in size, too little brain cushion, and/or reduce the nutrient absorption and waste removal process.
- One embodiment of the present invention addresses this issue by utilizing an electromechanical valve which adjusts and regulates the flow of the valve with the use of sensors measuring CSF pressure and flow.
- One or more micro-accelerometer sensors are integrated into the shunt valve or placed along the catheter tubing, these sensors are used to detect the movement and orientation (e.g., supine or upright) of the patient.
- the physician calibrates the micro-accelerometers by creating baseline orientations of the patient at different body positions.
- the accelerometers determine whether the patient is supine, upright, partially supine, partially upright, etc.
- the accelerometers determine the patient is moving from a supine/horizontal position to an upright position
- a signal is sent to the electromechanical valve to reduce the flow to prevent over drainage of CSF.
- Small changes can also be made as small changes are observed (e.g. as a patient goes from a sitting position to a standing position, or a slouched position to a straightened position).
- the CSF shunt could also be programmed with an AI algorithm whereby a downstream flow sensor (e.g., one in the drainage catheter) is used to detect the effectiveness of the last occurrence the valve was adjusted to prevent over-siphoning/over-drainage of CSF.
- the settings of the valve based on various body positions are stored in the memory of the device, where after each occurrence the program uses stored historical data to pinpoint the best settings to prevent siphoning based on body position changes, and the corresponding flow characteristics of the electromechanical shunt valve. In this manner, the patient would have the most optimal settings for anti-siphoning and require less visits to the physician for valve adjustments.
- the system can also be used with the wireless system described above and shown in FIG. 21 to communicate and monitor ICP characteristics, where the position of the user is another measurement the system is configured to monitor and adjust based on observed phenomena.
Abstract
Description
- This application is a divisional of U.S. patent application Ser. No. 16/403,360 filed May 3, 2019 entitled Treatment For Hydrocephalus, which claims benefit of and priority to U.S. Provisional Application Ser. No. 62/666,636 filed May 3, 2018 entitled Treatment For Hydrocephalus And Ventriculoperitoneal Shunt, both of which are hereby incorporated herein by reference in their entireties.
- Cerebrospinal Fluid (CSF) is a fluid found in the brain and spinal cord. CSF is produced in the choroid plexus of the ventricles of the brain and serves several purposes—including acting as a cushion for the brain, acting as a mechanism for delivering nutrients from and removing waste from the brain, and regulating changes in pressure within the brain. When CSF production exceeds its absorption, the pressure from CSF rises which can lead to an abundance of CSF—this in turn can result in hydrocephalus, which is swelling of the brain due to buildup of CSF. Hydrocephalus can cause balance and vision issues, increased head size, bleeding in the brain, cerebral edema, impaired brain function, brain herniation, as well as other issues.
- One method to treat hydrocephalus is known as shunting, which involves routing the CSF from the brain to another region of the body, such as the abdomen, lung, or heart. One popular routing area is the peritoneal cavity in the abdomen; routing from the brain ventricles to the peritoneal cavity is known as Ventriculoperitoneal (VP) shunting. The shunt system utilizes a ventricular catheter in the brain to collect and route the CSF, a second drainage catheter to redirect the CSF to another region of the body (e.g., the peritoneal cavity), and a valve in between to regulate flow of CSF from the brain to the drainage region.
- There are several complications associated with shunting. One is that the CSF can clog the catheter over time, this problem is more pronounced in the ventricular catheter since it has more exposure to CSF. This clogging can dilute the effectiveness of shunting and necessitate replacement over time. Next, it can be difficult to calibrate the valve correctly to drain the correct amount of CSF from the brain—draining too much CSF will decrease the available CSF while draining too little will not address the issue of hydrocephalus. Furthermore, the typical mechanical valves which regulate CSF flow to the drainage system have high failure rates for a variety of reasons.
- There is a need for a shunting device and system that addresses these issues.
- The present invention relates to devices, systems, and methods designed to address issues with the shunting procedure.
- In some embodiments, a shunting system includes a cleaning mechanism designed to clean residue from CSF in the ventricular catheter of a broader shunting system. In one embodiment, the cleaning mechanism includes a spring plunging element used to clean slits that allow CSF passage. In one embodiment, the cleaning mechanism includes a cleaning piston element used to clean slits allowing CSF passage. In one embodiment, the cleaning mechanism includes a rotational element used to clean slits allowing CSF passage.
- In one embodiment, a ventricular catheter used in a CSF draining shunt system includes slits to facilitate CSF drainage and biodegradable or bioresorbable material along one or more of these slits.
- In one embodiment, a locking mechanism facilitating secure fitting between a catheter tubing and a shunt valve element is described.
- In one embodiment, a mechanical valve utilizing a weighted or thinned disc portion is described. The mechanical valve regulates CSF flow within a valve housing, between a CSF inlet and CSF outlet.
- In one embodiment, a hydrogel is utilized to seal a hole opening used to gain vascular access during the CSF shunting procedure.
- In one embodiment, an electrical system used to monitor and/or communicate patient data associated with a CSF shunt system is described.
- In one embodiment, the shunt system includes a mechanical, electromechanical, and/or an electrical mechanism to selectively regulate CSF flow.
- These and other aspects, features and advantages of which embodiments of the invention are capable of will be apparent and elucidated from the following description of embodiments of the present invention, reference being made to the accompanying drawings, in which:
-
FIG. 1 illustrates a shunt system. -
FIG. 2 illustrates a ventricular catheter with a plurality of slits allowing entry of CSF. -
FIG. 3 illustrates a spring-plunger cleaning mechanism in an extended configuration used with a ventricular catheter, according to one embodiment. -
FIG. 4 illustrates a spring-plunger cleaning mechanism in a retracted configuration used with a ventricular catheter, according to one embodiment. -
FIG. 5 illustrates a closer view of the spring-plunger cleaning mechanism ofFIG. 3 in an extended configuration. -
FIG. 6 illustrates a closer view of the spring-plunger cleaning mechanism ofFIG. 4 in a retracted configuration. -
FIG. 7 illustrates a fixed piece of a spring-plunger cleaning mechanism, according to one embodiment. -
FIG. 8 illustrates a movable piece of a spring-plunger cleaning mechanism, according to one embodiment. -
FIG. 9 illustrates an inner lumen of a movable piece of a spring-plunger cleaning mechanism, according to one embodiment. -
FIG. 10 illustrates an inner lumen of a movable piece of a spring-plunger cleaning mechanism, according to one embodiment. -
FIG. 11 illustrates a ventricular catheter utilizing a plurality of small CSF entry slits usable with a cleaning mechanism, according to one embodiment. -
FIG. 12 illustrates a cleaning mechanism utilizing a spring and piston in an extended configuration, according to one embodiment. -
FIG. 13 illustrates a cleaning mechanism utilizing a spring and piston in a contracted configuration, according to one embodiment. -
FIG. 14 illustrates a ventricular catheter utilizing a plurality of small slits which can be used with a cleaning mechanism, according to one embodiment. -
FIG. 15 illustrates a shunt valve interface. -
FIG. 16 illustrates a locking mechanism for a shunt valve interface, according to one embodiment. -
FIG. 17 illustrates a shunt valve system, according to one embodiment. -
FIG. 18 illustrates the valve used in the shunt valve system ofFIG. 17 , according to one embodiment. -
FIG. 19 illustrates a top disc used in a valve, according to one embodiment. -
FIG. 20 illustrates a bottom disc used in a valve, according to one embodiment. -
FIG. 21 illustrates a flowchart for an electrical communication system used as part of a shunt system, according to one embodiment. - Specific embodiments of the invention will now be described with reference to the accompanying drawings. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. The terminology used in the detailed description of the embodiments illustrated in the accompanying drawings is not intended to be limiting of the invention. In the drawings, like numbers refer to like elements.
- Excessive CSF production and retention which causes hydrocephalus and its associated problem states were highlighted in the previous background section. Shunting is one technique used to address hydrocephalous and excessive CSF. This approach utilizes a catheter to drain Cerebrospinal Fluid (CSF) from the brain, a catheter used to convey the CSF to another region of the vascular, and a valve in between to regulate the flow of CSF between the two catheters. This valve ensures the right amount of CSF is drained from the brain. Too much CSF drainage will cause adverse effects since there will not be enough CSF to perform its natural function—including acting as a cushion for the brain, acting as a mechanism for delivering nutrients from and removing waste from the brain, and regulating changes in pressure within the brain. Too little CSF drainage will still leave the patient dealing with the problem of excessive CSF, including hydrocephalus.
- The shunt system can redirect the CSF to various areas of the body including lungs, heart, or other regions of the brain. VP shunting, involving redirection of the CSF to the peritoneal cavity in the abdomen, is one popular shunting technique. Though the shunting systems, devices, techniques, and methods described in the inventive embodiments herein will often be described for us with VP shunts (that is, shunting systems routing CSF to the abdominal section), it can also be used in shunt systems redirecting CSF elsewhere in the body/vasculature.
-
FIG. 1 shows the broad overview of aVP shunt system 100. The shunt acts to move CSF from thebrain 102 to the abdominalperitoneal cavity 110. Here, the shunt system includes a collection orventricular catheter 104 collecting CSF in the ventricles of the brain and conveying CSF away from the ventricles ofbrain 102. The system further includes a secondary exit ordrainage catheter 108 to direct the collected CSF into theperitoneal cavity 110 of the abdomen. Avalve 106 regulating flow between the two catheters is between the twocatheters valve 106 can include a number of mechanical/electrical valve mechanisms commonly known in the art to regulate the flow. - Shunting has relatively high failure rates, there are an estimated 18,000-33,000 shunts placed each year in the US however up to ⅓ of these fail within the first year and up to 50% fail within the first two years. The causes of failure are numerous, including mechanical failure with the flow valve which drains CSF, and material buildup in the catheters which causes blockages. Often times the CSF has proteins or calcium and these materials can build up in the catheters, leading to clogging of the catheter draining system. This problem is more pronounced in the ventricular catheter which acts as the entry point for the brain CSF to enter the shunt system, and which therefore is exposed to more CSF. Over time, this can lessen how effective shunting is to redirect CSF as the catheter gets filled with more material buildup. Over time this may necessitate the implantation of a new ventricular catheter or an entirely new shunting system.
- The
ventricular catheter 104 is shown in more detail inFIG. 2 . Theventricular catheter 104 typically includes a number of holes or slits 114 spaced along the end section of the catheter (i.e., the portion of theventricular catheter 104 which is farthest relative tovalve 106, which is the portion of theventricular catheter 104 which will be exposed to CSF in the ventricles). These holes or slits 114 act as entry conduits for the CSF to enter theventricular catheter 104. A number of spaced holes/slits are preferred so there are ample points of entry for the CSF to enter the catheter, thereby maximizing the drainage potential. Though four holes/slits 114 are shown inFIG. 2 , this is just illustrative and fewer or more holes can be used, including said slits or holes being located along various portions of theventricular catheter 104. These holes or slits 114 are often where the matter buildup from CSF (e.g., protein or calcium deposits) tends to accumulate. Over time as the material builds up in these entry ports, less and less CSF is able to enter the ventricular catheter—in turn inhibiting the ability of the shunt system to function effectively to drain CSF. The following inventive embodiments presented address this issue by providing various mechanisms used to clean these slits or holes. -
FIGS. 3-4 illustrate one embodiment of acleaning mechanism 120 used to clean the CSF entry slits 114 ofventricular catheter 104. Themechanism 120 is built over a section of theventricular catheter 104 and sits over the CSF entry holes 114.Cleaning mechanism 120 utilizes a reciprocating approach to clean the entry slits 114, wherein the mechanism has a first expanded position where it covers the slit and a second contracted position where the slits is exposed. In one embodiment, onemechanism 120 is used for each slit of the ventricular catheter. In one embodiment, eachmechanism 120 covers a plurality of slits so that a plurality of slits are cleaned with eachcleaning mechanism 120. In one embodiment,cleaning mechanism 120 utilizes a spring plunger as the basis of the reciprocating motion—shown in more detail inFIGS. 5-6 .Cleaning mechanism 120 utilizes a spring plunger system which includes a fixedbase piece 122 andmovable reciprocating piece 132. The fixedbase piece 122 has aplatform 124, with one ormore springs 126 connected to the platform. One end of spring(s) 126 is connected to theplatform 124 while the other end of spring(s) 126 is connected to thereciprocating piece 132. The reciprocating piece is hollow in that it is not completely solid—preferably this involves the use of a thin outer wall and a thin inner wall, where the springs are located between these two wall sections. In this manner thespring 126 can connect to thereciprocating piece 132.Base piece 122 andreciprocating piece 126 each include an inner lumen, this lumen is necessary so that theentire cleaning mechanism 120 can slide over the ventricular catheter; therefore, the inner lumen of thebase piece 122 and the inner lumen of thereciprocating piece 132 will be larger than the outer diameter of theventricular catheter 104. These lumens are shown in more detail inFIGS. 7-8 , where fixedpiece 122 includes aninner lumen 122 a which is sized larger than the ventricular catheter outer diameter andmovable piece 132 also includes aninner lumen 132 a sized larger than the ventricular catheter outer diameter. - Though one or more spring(s) 126 are contemplated, in one embodiment, a plurality of
springs 126 are used which are spaced in equivalent circumferential intervals along the inner part of themovable piece 132. When springs 126 are fully elongated, the reciprocating piece will be located in its farthest position relative to the base piece, as shown inFIGS. 3 and 5 ; this corresponds to thereciprocating piece 132 covering an associatedslit 114. When thesprings 126 are fully compressed, the reciprocating piece will retract relative to the base piece, as shown inFIGS. 4 and 6 ; this corresponds to thereciprocating piece 132 exposing an associatedslit 114 thereby facilitating easier entry of CSF into the associated slit/hole 114. -
Base piece 122 andmoveable piece 132 are shown in more detail inFIGS. 7-8 .FIG. 7 shows thebase piece 122, which includes theinner lumen 122 a which allows the piece to be mounted over the ventricular catheter.Inner lumen 122 a should therefore be a larger size than the ventricular catheter so that it can be placed over it, as described above. The fixed/base piece 122 also includes aplatform 124 which the one ormore springs 126 are attached to, as discussed above. -
FIG. 8 shows movable/reciprocating piece 132 in more detail. Themovable piece 132 is movable relative to both theventricular catheter 104 and the fixedpiece 122.Movable piece 132 includes itsown lumen 132 a so that it can be placed over the ventricular catheter and is therefore sized larger than the ventricular catheter, as described above. Thislumen 132 a is preferably sized larger than fixedpiece 132 so that themovable piece 132 can slide over fixedpiece 122, in the manner shown inFIGS. 4 and 6 when the springs are compressed.Movable piece 132 is hollow in that there is a first outer wall defining the outer perimeter of themovable piece 132, a second wall defining theinner lumen 132 a, and open space in between. Thesprings 126 span this open space channel section and are attached to the interior of themovable piece 132. The other end of spring(s) 126 is attached to the platform section of fixedbase piece 122, as described earlier. Whilebase piece 122 is mechanically fixed to the ventricular catheter surface (e.g., through a connection medium such as adhesive, welds, or other means between the base pieceinner lumen 122 a and the underlying ventricular catheter), themovable piece 132 is not fixed and in this manner it reciprocates to adopt the positions shown inFIGS. 5-6 assprings 126 contract and elongate. Since theinner lumen 132 a ofmovable piece 132 is larger than the width or diameter of the fixedpiece 122, themovable piece 132 overlaps the fixedpiece 122 when the spring is collapsed—as shown inFIGS. 4 and 6 . - The one or
more springs 126 connecting thebase piece 122 to reciprocating/movingpiece 132 will compress and elongate along with the pressure of the region, which will vary based on blood flow due to the pumping of the heart. Therefore, there should be a relatively consistent cycle of elongation and compression that tracks to the heartbeat and natural flow of blood through the vasculature that results. In this manner, batteries, motors, or other external drivers will not be needed to control the position ofmovable piece 132, although certain embodiments may utilize these additional elements to electromechanically control the position ofmovable piece 132. - In terms of the mechanism used to clean the
slits 114 as themovable piece 132 passes over them, this can be done in a number of ways. In one embodiment, the wall forming the circumference ofinner lumen 132 a can include one or more projecting structures that project radially inward withinlumen 132 a. In this manner, the projecting structures would either graze or physically enter into a portion of theslits 114 as themovable piece 132 passes over the slits, thereby cleaning them. In another embodiment, the wall can include a roughened or abrasive surface which projects slightly intolumen 132 a, and which would graze or project slightly into the slits as the movable piece passes over the slits. In another embodiment, one or more brushes are utilized which project frominner lumen 132 a. These configurations are shown inFIGS. 9-10 where a projecting element (such as a bar), roughened/abrasive elements, or brush-like elements 134 are shown as extending from within the interior of theinner lumen 134 of themovable piece 132. These cleaningelements inner lumen 132 a or could extend from the interior of themovable piece 132 and pass through into theinner lumen 132 a. - Since the
inner lumen 132 a ofmovable piece 132 is sized larger than the fixed piece 122 (in the manner described earlier, in order to facilitate movement over the fixed piece 122), the projections or roughened surfaces may have to be particularly lengthy in order to contact the holes of the ventricular catheter. One way to mitigate this is to include another smaller internal secondary lumen onmovable piece 132, which functions to also fit over the ventricular catheter. Including the smaller secondary lumen will minimize the gap between the ventricular catheter, and including the projections or roughened regions utilized in this smaller secondary lumen will mean the projections/roughened sections can be smaller and still contact the holes or slits to clean them. - In one embodiment, the slits only sit on one side of the catheter, and the inner lumen has projections, abrasions, brushes, or the
cleaning surface 134 sitting only along one face of the lumen, as shown inFIGS. 9-10 . In another embodiment, the slits are along opposing sides of the catheter. The cleaning surface can then sit along both sides of the lumen to clean the slits on either end. In one embodiment, the cleaning surfaces of theinner lumen 132 a ofmovable piece 132 are radially and/or longitudinally spaced throughout all or a portion of theinner lumen 132 a (therefore, located in various areas of theinner lumen 132 a). - In one embodiment, a plurality of
slits 114 are used along theventricular catheter 104 and some or all of these slits are configured such that each slit utilizes its own individual cleaning mechanism 120 (as shown inFIG. 4 ). In one embodiment, a plurality of cleaningmechanisms 120 are used and themovable pieces 132 are connected to each other (e.g. via springs). In this way the motion of some or all of themovable pieces 132 ondifferent cleaning mechanisms 120 can be coordinated together whereby themovable pieces 132 will extend in unison and retract in unison (and not solely relying on the pulsatile nature of blood flow). In those embodiments where an external electromechanical driver is used to drive the movement ofmovable piece 132, these cycles can be coordinated through a common driver or through a plurality of drivers that are synced together. - In one embodiment (shown in
FIG. 11 ), theventricular catheter 104 may utilize a number oftiny slits 144, rather than utilizinglarger slits 114 that are sized so that a single cleaning mechanism can be used for each slit. With this embodiment, a single springplunger cleaning mechanism 120 as described and shown above inFIGS. 3-10 can be utilized to clean a plurality of these slits. For instance, onecleaning mechanism 120 will span the plurality of slits shown inFIG. 11 . The plurality of cleaningsurfaces 134 of theinner lumen 132 a of the movable piece 130 will be used to clean a number of the smaller slits 144. In this manner, onecleaning mechanism 120 can be used to clean a plurality (or all) of theslits 144. In another embodiment, the slits are spaced out over the ventricular catheter in different segments and each segment utilizes itsown cleaning mechanism 120 to clean the plurality of slits in that particular catheter segment. The movable pieces can optionally be linked as described above so that the movable pieces move in unison, or otherwise no linking is used and the pulsatile nature of blood controls the movement of the movable pieces (which should generally cause a relatively consistent movement pattern across all the movable pieces). - Another embodiment of a cleaning mechanism is shown in
FIGS. 12-13 . This embodiment utilizes ahousing 140 that overlaps an end section of a ventricular catheter 104 (e.g., the section of the ventricular catheter containing CSF entry holes or slits 114). The inside of thehousing 140 contains apiston cleaning element 146 with athickened end region 148, and aspring 150 connected to the piston such that the piston can reciprocate between a proximally oriented configuration and a distally oriented configuration, as shown inFIGS. 12-13 . The spring extends and compresses based on various variables. In one example, as CSF collects in the housing, it exerts pressure against thepiston 146 andconnected spring 150. As this pressure increases, this causes the spring to compress and the attached piston to retract exposing some of theholes 114 of the ventricular catheter and allowing the CSF to then enter theventricular catheter 104 through theseholes 114. In this way, CSF enters the ventricular catheter in a controlled manner depending on how much CSF has accumulated in/near thehousing section 140 of the ventricular catheter. The piston has an inner lumen which is sized slightly larger than the ventricular catheter end section, and in this way the piston 146 (as well ashousing 140 and spring 150) sit around the ventricular catheter. The inner lumen utilizes the various projections, brushes, or roughened surfaces discussed earlier with regard to the embodiments shown and discussed inFIGS. 3-10 (particularly highlighted inFIGS. 9-10 and associated elements 134). These cleaningelements 134 work in a similar manner to clean theholes 114 as the piston moves back and forth over theholes 114. Thethickened end region 148 of the piston slightly contacts the housing and functions to clean the interior surface of the housing from the CSF buildup. Thisend region 148 can contain a similar projection, brush, or abrasive interface to help clean or scrape the buildup from the interior of thehousing 140. Thishousing element 140 is preferably placed on the very end section of the ventricular catheter where the CSF accumulates in the neurovasculature, in one example this end catheter section would sit within the cerebellopontine angle cistern section of the neurovasculature. - One advantage of the cleaning interface of
FIGS. 12-13 is that the CSF drainage is metered since as the CSF accumulates, it exerts pressure on thepiston 146 andspring 150. As this pressure increases, it pushes the piston and spring toward the configuration ofFIG. 13 exposingmore holes 114 as the pressure mounts, thereby increasing the CSF drainage as the pressure increases. Over drainage of CSF is problematic since a certain amount of CSF is needed in the brain to cushion the brain and to help promote proper nutrient absorption. Under-drainage of CSF is bad since this will then cause too much CSF to accumulate leading to increased pressure on the brain and hydrocephalus. In the manner of this embodiment, the CSF drainage is controlled based on the accumulated pressure exerted by the CSF, so some CSF is allowed to accumulate but excess CSF will cause drainage as the pressure builds-up owing to the piston/spring interface. In some examples, the spring tension and piston weight can be customized to precisely control the amount of CSF drainage allowed. In some embodiments, an electrically integrated system is utilized where the spring tension is mechanically customized and altered based on passive measurements taken by an integrated electrical-based measuring system so that the proper drainage is customized based on a measurement system measuring CSF pressure (of the pressure CSF is exerting against thepiston 148 and/or spring 150). - In another embodiment similar to the concepts of
FIGS. 12-13 , a rotating element is connected to a mechanical rod within thehousing 140 and this rotating element circulates within the interior of the housing cleaning theholes 114. The rotating element would be located circumferentially around theventricular catheter 104 between in the space between the catheter and the housing. The rotating element is a disc (with a lumen larger than theventricular catheter 104 so as to be placed around said catheter) and can utilize various projections or brushes to clean the slits/holes 114. In one embodiment, the disc moves proximally and distally utilizing a connected spring-element, similar to the embodiments ofFIGS. 12-13 . In another embodiment, one or more discs are used which span a plurality of holes lengthwise along thecatheter 104. In another embodiment, noexternal housing 140 is used—instead, the internal section of thecatheter 104 utilizes an end rotating disc element which rotates to clean thevarious slits 114. In one embodiment, the disc is capable of proximal and distal movement, for instance via connection to an end spring similar to thespring 150 ofFIGS. 12-13 . - Other embodiments of the present invention can address the issue of CSF and associated matter accumulation along the ventricular catheter fluid entry locations by utilizing particular coatings on the ventricular catheter surface of the section of the ventricular catheter containing CSF entry holes 114. These coatings can either be in addition to the cleaning mechanism concepts discussed above or can be used as a stand-alone solution. For instance, the ventricular catheter or entry holes 114 can be coated with a plasma protein adsorption suppressant, such as, but not limited to, Poly(2-methoxyethylacrylate) (PEMA or X-Coat). Additionally, antibacterial coating can also be used to prevent infection. The entry holes 114 and catheter inner lumen can also be customized to help prevent clogging and obstruction from CSF buildup, for instance larger entry holes and a larger inner lumen can be used to help prevent clogging. Furthermore, the inner wall of the
ventricular catheter 104 can also utilize these coatings to prevent material buildup within the catheter itself. - Other embodiments can utilize a biodegradable or bioresorbable material to cover CSF entry holes 114, whereby the material will degrade or resorb over different time periods to expose the holes. The idea here is that as some holes not utilizing this material get clogged with CSF over time, other holes with degradable or resorbable covering material (which disappears or degrades over time) will then open up allowing CSF to drain through these other holes. The ventricular catheter will be manufactured with extra holes or slits 114. Afterwards, some of the holes will be covered up by a thin film of biodegradable or bioresorbable material such as, but not limited to, polyalpha-hydroxy-acids and/or polyesteramide (PEA), that will take a set amount of time to resorb. Materials with multiple/different resorption rates can be used to cover various holes; this difference in resorption rate can be due to a thicker vs thinner amount of covering material, or alternatively due to different materials being used which have different resorption rates. Additionally, a layer of coating can be applied on the catheter (and/or the flow control valve connected to the ventricular catheter to selectively allow the CSF to drain out of the drainage catheter into the abdomen) to further prevent protein adsorption.
FIG. 14 shows an example of a multiple resorption approach, whereholes 114 a are designed as completely open (meaning, without a coating) so these holes will be the initial ones CSF will flow into (but may also clog over time).Holes 114 b utilize a membrane which resorbs after, for example, 12-24 months—meaning these holes will fully open at 12-24 months which will help account for the portion ofholes 114 a which get clogged.Holes 114 c can then utilize a membrane covering which resorbs at about 3-4 years, which will help account for the portion ofholes 114 a-114 b that get clogged. This pattern can continue with various hole segments along the length of theventricular catheter 104. These holes with different resorption rates can also be spaced in different locations along the catheter to produce a more randomized profile. In this way, as certain holes get clogged, others will open and there is less likelihood of a majority or a plurality of holes all clogging at around the same time (which would undesirably decrease the CSF drainage effectiveness). This approach decreases the chance that a new ventricular catheter will have to be implanted, or at least spaces out the intervals where this procedure will have to be undertaken. One additional advantage of this approach is that a calibrated CSF drainage protocol is maintained. While some holes get clogged over time thereby decreasing their CSF entry/drainage potential, others newly open thereby roughly balancing the total amount of holes/slits available at any given time to evacuate CSF. - The coatings can be applied in various locations, including along the slits/holes/
openings 114 of the ventricular catheter, as described. In one embodiment the coating projects outwardly from the holes. In one embodiment the coating is applied such that it projects radially inward from the holes. In one embodiment the coating is flush with the plane of the hole itself. The coating can be applied in a variety of manners including through a mechanical (hand) coating process, or by machine. In one embodiment, the entire catheter (or a portion of the catheter) itself is dipped in the coating solution where the coating is equally applied through the dipped section of the catheter. In some embodiments, the drainage catheter also utilizes the coating in order to prevent bacterial or material buildup. In some embodiments, the coating is utilized along the section of the catheter immediately adjoining the valve so prevent material buildup from interfering with the mechanical valve apparatus. - Aside from ventricular catheter clogging, another complication with the shunting procedure is ensuring the ventricular catheter (which sends CSF from the neurovasculature to the shunt valve apparatus) and the drainage catheter (which routes the CSF from the shunt valve apparatus to the drainage location, such as the abdominal cavity) stay connected to the valve apparatus. If either of these catheters become disconnected or loosened, it limits the ability of the shunt to effectively withdraw and route CSF from the brain. The following embodiments address this issue by providing a locking mechanism to enable a better connection between the shunt valve and the connected catheters.
-
FIG. 15 shows a typical shunt connective interface. The typical system includes a shunt housing/valve 200 which includes a valve element to selectively meter CSF. There is also a first 202 and second 204 connective interface/fitting which connect respectively to a ventricular catheter (a first end of which is in the CSF accumulation region of the brain, and a second end of which is attached to the connective interface 202) and a drainage catheter (a first end of which is attached to theconnective interface 204 and a second end of which routes to the drainage region, e.g. the abdomen). The typical interface includes aridge -
FIG. 16 shows an embodiment of a connective interface or fitting 206 (this fitting can represent one or either of the twofittings connection elements 206 a. These elements are female depressions or recessions that extend into the surface of the fitting 206, male projections that extend outwardly from the surface of the fitting 206, or some combination of the two. The end section of the catheter—in particular, the section of the catheter that is placed over the fitting—contains a corresponding interface (e.g., a projection that mates with the depression of the fitting 206, a depression that mates with the corresponding projection of the fitting 206, etc.) such that the catheter and fitting are bound by the mating between the respective interfaces. A portion, or all of theconnection elements 206 a can be used whereby the catheter can utilize its own corresponding mating interface that links with a portion or all of theconnection elements 206 a. In one example, the blackenedconnection elements 206 a ofFIG. 16 can be considered as projections that extend outwardly from the fitting 206, while the whitenedconnection elements 206 a can be considered as recesses that inwardly recede from the fitting 206. The corresponding interface surface on the end of the connecting catheter will then have corresponding surfaces to mate with this region (e.g., a recessed or female area to mate with blackenedprojection 206 a, and a male projection to mate with whitenedfemale recess 206 a). Not all of theconnection elements 206 a have to be engaged. For example, a portion of theconnection elements 206 a are actually used to bind the fitting to the overlying catheter. In one embodiment, only projections or only recessed sections are used. For example, thefitting interface 206 a utilizes only female depressed structures and the catheter interface comprises only male projecting structures—alternatively, thefitting interface 206 a is only male projection structures and the catheter interface comprises only female recessed structures. - Typical shunt valves utilize a one-way valve design comprising a ruby ball that presses against a spring, where the valve opens up once a certain pressure is reached to allow CSF passage through the valve outlet section and into the drainage catheter. Sometimes, magnets are further used to optimize the desired CSF flow rate for each patient. However, due to the large number of mechanical parts, mechanical failure of valve components is common. The following embodiments discuss a valve concept utilizing fewer mechanical parts to address this valve failure issue.
- A
shunt valve housing 200 is shown inFIG. 17 , including aninlet end 202 connected to a ventricular catheter which collects CSF and anoutlet end 204 connected to a drainage catheter which drains CSF. In the context ofFIG. 17 , CSF will flow left to right.Valve housing 200 includes a pre-chamber 208 and avalve chamber 209 containing avalve 210, where CSF initially follows into the pre-chamber 208 and then into thevalve chamber 209. Thevalve chamber 209 contains atop section 209 a and abottom section 209 b, and avalve 210 in between the two sections modulating flow therebetween. -
Valve 210 is shown in more detail inFIG. 18 and includes astem 214 and aprotruding anchor 212 where the anchor is anchored to the top section ofvalve chamber 209 through a hole. There areinlet holes 211 around the anchor allowing inflow of CSF as shown inFIG. 17 .Valve 210 includes atop disc 216 and abottom disc 218; both discs are respectively shown in more detail inFIGS. 19-20 and contain a middle hole allowing passage of thevalve stem 214 whereby thevalve stem 214 binds the two discs together. The mechanical valve operation, which is how thevalve 210 opens and closes, will now be explained in more detail. - The
valve 210 comprises atop disc 216 and abottom disc 218, as described above.Top disc 216 contains a number ofholes 220 which are aligned with the inlet holes 211 of thevalve chamber 209. Once CSF enters thevalve chamber 209, it will flow through inlet holes 211 and into theholes 220 of thetop disc 216. Thebottom disc 218 does not have such a plurality of holes, instead it is weighted such that the a portion of the bottom disc 218 (e.g., the right side of the disc which is the portion which faces the outlet 204) is lighter than the other portion (e.g., the left side). This variable weighting can be accomplished in a number of ways—such as by using lighter material on the lighter portion of thebottom disc 218, or by making a portion of the bottom disc thinner. The CSF weight and pressure increases as it accumulates into the top section of thevalve chamber 209 and enters the holes of thetop disc 216, the weight will increase whereby the lighter section of thebottom disc 218 will eventually pivot allowing the CSF to exit. This pivoting action means that thestem section 214 is either slightly longer than the bottom disc or is not fixed directly to thebottom disc 218, meaning thebottom disc 218 has some give and has some slight degree of movement as the CSF weight increases. - If enough CSF accumulates, the heavier or thicker left side of the bottom disc will also pivot allowing CSF to now exit through the bottom chamber of the
valve chamber 209. In this manner, thevalve 210 has a closed configuration when the CSF threshold weight is not surpassed where the top and bottom discs are snug so that CSF cannot exit the valve. Thevalve 210 next has a partially open configured where the thinner or lighter portion of the bottom disc 218 (e.g., the section of the disc which is closer to theoutlet end 204 of the shunt valve system) opens to allow partial CSF outflow. Finally, thevalve 210 has a fully opened configuration where the entirebottom disc 208 opens or pivots with respect to the top disc allowing maximum drainage of CSF. - In one embodiment, the valve's 210
discs top disc 216 is about 0.07″ thick and contains 6-8holes 220 around the perimeter.Bottom disc 218 decreases in thickness as it moves around the disc circumference, as discussed above, where the thickest section is about 0.07″ and the thinnest section is about 0.02″. Though the earlier description specifically discussed the portion of thebottom disc 218 facing theoutlet 204 as the thinnest, in practicality it would not necessarily matter which section ofbottom disc 218 is thinner since the CSF will likely accumulate in thebottom chamber 209 b of thevalve chamber 209 and then be pushed through theoutlet 204 once the bottom chamber fills with CSF. Therefore, as long as any portion of the bottom disc 219 is thinner (or lighter), it will allow CSF to drain from the upper section of thevalve chamber 209 once a threshold weight or pressure is reached. This design will therefore create a pressure gradient one-way valve, where the two-disc interface prevents CSF from flowing backwards. - The purpose of
pre-chamber 208 is to accumulate CSF prior to it entering thevalve chamber 209. However, in some embodiments, the pre-chamber 208 can also be used for hypodermic sampling of CSF, and/or can used to test for proper valve function. The pre-chamber can be pressed down or palpated/palpitated for testing purposes. For instance, the valve flow can be configured so a certain amount of fluid always stays in the pre-chamber while not enough fluid stays in the pre-chamber so as to completely fill it. If the pre-chamber bubble cannot be pressed down, it will indicate distal catheter obstruction since the pre-chamber will be completely filled. Meanwhile, if the pre-chamber bubble stays down after being pressurized, it would indicate proximal catheter obstruction—therefore the pre-chamber material characteristics can be configured to act as an indicator of proper functionality of the ventricular (brain) catheter and the drainage (abdominal) catheter. - Often times with the shunt procedure or to otherwise remove excess CSF, a hole is created in the third ventricular area of the neurovasculature to remove excess CSF and reduce pressure on the brain. Often times this procedure is used instead of the shunt procedure or in concert with the shunt procedure to provide a drainage path for CSF back within the bloodstream. However, sealing this opening can be difficult. Hydrogels are a class of compounds that expand or swell in response on a particular stimulus. Hydrogels for vascular therapeutic purposes are often designed to expand based on contact with aqueous material (e.g., the aqueous portion of blood) or based on pH (e.g., the pH of blood). In one embodiment, hydrogels such as but not limited to polyethylene glycol or polytetramethylene oxide can be applied to the area to help seal the created opening. In one embodiment, a portion of the distal tip of the ventricular catheter (meaning the end portion of the ventricular catheter within the neurovasculature CSF accumulation point) utilizes hydrogel, such as the portion that is about 5 centimeters away from the distal tip, to help seal the opening. Alternatively, the hydrogel can be applied using a syringe after the catheter is placed in position within the ventricles of the neurovasculature. Similarly, if a shunt valve is placed endovascularly, a vein such as the inferior petrosal sinus may be punctured to place the valve. The hydrogel can be applied to the tip of the shunt where the shunt is anchored into the vessel wall to seal the puncture and to help keep the shunt firmly in place.
- Many of the embodiments presented herein have addressed the problem associated with the clogging of the ventricular catheter or valve failure, where various mechanically-oriented devices and systems were described to address this issue. This problem can also be solved through an electrical communication system utilizing wireless communication protocols to monitor convey changes in intracranial pressure whereby any blockages or other issues with the CSF draining procedure would result in a noticeable increase in intracranial pressure (ICP). ICP is measured over a given time interval and maximum and minimum pressure are stored and analyzed to provide a meaningful representation of ICP, whereby significant deviations would indicate an issue with the shunt system. The information is then transmitted wirelessly through communication protocols such as, but not limited to, Bluetooth Low Energy (BLE) to provide advanced warning of changes in ICP to alert the patient. This information is then wirelessly transferred to portable wireless enabled devices such as watches, mobile phones, mobile computers, etc. The steps and elements required for this system is represented in the flowchart of
FIG. 21 . - The pressure sensor which is included in the flowchart of
FIG. 21 is used to monitor ICP and in one embodiment uses a micro-electromechanical (MEMS) silicon-based pressure sensor. The silicon-based pressure sensor utilizes the proportional change of resistance elements located within the sensor. The pressure sensor could be placed anywhere within the shunt system, including within the ventricular catheter, valve housing, or drainage catheter—additionally various pressure sensing elements could be placed in different areas of the shunt system (e.g., one in the ventricular catheter and one in the valve housing) to create a broader ICP representation as well as help identify where any blockage is located. Alternatively, a separate pressure sensor can be implanted near the ventricular catheter so that the pressure represents the ICP physically within the ventricular region where the CSF accumulates. - The flowchart also includes an antenna system used to convey data to a wireless enabled device (e.g., a watch, smartphone, computer, or tablet). One embodiment for the antenna portion of the electrical system utilizes a non-magnetic conductive trace pattern (e.g., utilizing gold-plated copper, platinum, beryllium) which is designed into the surface of the shunt catheter and connected to the antenna interface circuitry. The conductive section links a measurement taking sensor (such as the pressure sensor) to the antenna to transmit the relevant data or links the controller which compiles the relevant data to the antenna for transmittal. The conductive pattern is designed to have optical radio frequency transmission characteristics over the selected wireless communication protocol (for instance, BLE frequencies of 2.4-2.4835 GHz).
- Another embodiment for the antenna portion of the electrical system utilizes a ventricular anchor. The ventricular anchor exits the CSF accumulation vein of the neurovasculature, and the catheter then is located within the vein, whereby the anchor serves to keep the ventricular catheter in place. This embodiment utilizes a ventricular anchor comprised of conductive material (e.g., stainless steel, platinum cobalt chromium, etc.) with geometry sized for the RF transmission characteristics of the frequencies required, where the anchor itself acts as the antenna or acts as the conductive electrical communication medium for the antenna.
- The power requirements for the electrical system is relatively low, requiring approximately 3-4 microwatt-hours each time the ICP is measured and the relevant data transmitted. One embodiment utilizes an energy storage concept to utilizing a capacitive storage element embedded within the walls of the ventricular catheter. The capacitive storage element is constructed of two concentric tubes of different diameters, and the space between the two conductive tubes is filled with a dielectric material. The dielectric has a sufficient dielectric constant to provide large enough capacitance between the two tubes to store sufficient energy for the electrical system to operate. The capacitor is charged through an external charge source such as an inductively coupled charging station or energy harvesting (e.g., thermal, RF or piezo-electrical energy) controlled by the charge controller. Alternatively, the electrical system utilizes a hermetically sealed implantable battery utilizing a lithium-iodine or lithium-carbon fluoride battery.
- In one embodiment, the electrical communications system described above and shown in
FIG. 21 passively measures ICP to convey this information to an external device to relay this information to the user. In another embodiment, the electrical system varies the valve characteristics (e.g. loosens or tightens the valve to either augment CSF discharge or reduce CSF discharge) based on measured ICP data. As discussed above, a certain amount of CSF is needed so the shunt valve cannot constantly drain CSF but instead typically drains CSF once a certain pressure is exceeded. Typically, this system utilizes a mechanical valve which mechanically opens or mechanically enables flow once a threshold pressure is exceeded. In certain circumstances it can be difficult to design an optimum valve since every patient is different (for instance, each patient will have different brain sizes, different CSF production amounts, etc.). However, with the electrical system described above, the monitoring system itself can link to the valve and open or close the valve based on the calculated ICP to provide a customizable valve profile. In this way, once a certain threshold value is exceeded, the electrical system communicates with the valve and then opens the electro-mechanical valve. This threshold value can constantly be updated based on observed phenomena or can be calibrated based on a stored physician-enabled profile. This system can also be used to continuously monitor CSF and make continuous small adjustments valve to control how “open” the valve is to create a constantly updated valve profile where small adjustments in the valve opening profile are being made on a relatively continuous basis as needed. In this way, a master electrical communication system is used to monitor ICP. This system is then directly linked to the valve to adjust the valve to enable more CSF flow through the valve or limit CSF flow through the valve, as needed. - One issue with shunts is how the CSF drainage rate changes when a person goes from a supine or flat position (e.g. when sleeping) to an upright position. Due to gravity, this movement change can cause CSF to suddenly drain since the drainage catheter goes from a horizontal position to a vertical position as the patient sits upright. However, this increase in drainage can be undesirable since it is in response to a change in patient orientation, rather than resulting from an accumulation of CSF. CSF over drainage is risky because too little CSF in the neurovasculature can cause ventricles to collapse, tearing of blood vessels, headaches, subdural hematoma, slit ventricle syndrome where the ventricles decrease in size, too little brain cushion, and/or reduce the nutrient absorption and waste removal process. One embodiment of the present invention addresses this issue by utilizing an electromechanical valve which adjusts and regulates the flow of the valve with the use of sensors measuring CSF pressure and flow. One or more micro-accelerometer sensors are integrated into the shunt valve or placed along the catheter tubing, these sensors are used to detect the movement and orientation (e.g., supine or upright) of the patient. Once the shunt is implanted, the physician calibrates the micro-accelerometers by creating baseline orientations of the patient at different body positions. Once calibrated, the accelerometers determine whether the patient is supine, upright, partially supine, partially upright, etc. When the accelerometers determine the patient is moving from a supine/horizontal position to an upright position, a signal is sent to the electromechanical valve to reduce the flow to prevent over drainage of CSF. Small changes can also be made as small changes are observed (e.g. as a patient goes from a sitting position to a standing position, or a slouched position to a straightened position). In addition to pre-programmed flow adjustment based on body positions, the CSF shunt could also be programmed with an AI algorithm whereby a downstream flow sensor (e.g., one in the drainage catheter) is used to detect the effectiveness of the last occurrence the valve was adjusted to prevent over-siphoning/over-drainage of CSF. The settings of the valve based on various body positions are stored in the memory of the device, where after each occurrence the program uses stored historical data to pinpoint the best settings to prevent siphoning based on body position changes, and the corresponding flow characteristics of the electromechanical shunt valve. In this manner, the patient would have the most optimal settings for anti-siphoning and require less visits to the physician for valve adjustments. The system can also be used with the wireless system described above and shown in
FIG. 21 to communicate and monitor ICP characteristics, where the position of the user is another measurement the system is configured to monitor and adjust based on observed phenomena.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/935,882 US20230017481A1 (en) | 2018-05-03 | 2022-09-27 | Treatment For Hydrocephalus |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862666636P | 2018-05-03 | 2018-05-03 | |
US16/403,360 US11464952B2 (en) | 2018-05-03 | 2019-05-03 | Treatment for hydrocephalus |
US17/935,882 US20230017481A1 (en) | 2018-05-03 | 2022-09-27 | Treatment For Hydrocephalus |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/403,360 Division US11464952B2 (en) | 2018-05-03 | 2019-05-03 | Treatment for hydrocephalus |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230017481A1 true US20230017481A1 (en) | 2023-01-19 |
Family
ID=68384358
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/403,360 Active 2039-12-19 US11464952B2 (en) | 2018-05-03 | 2019-05-03 | Treatment for hydrocephalus |
US17/935,882 Pending US20230017481A1 (en) | 2018-05-03 | 2022-09-27 | Treatment For Hydrocephalus |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/403,360 Active 2039-12-19 US11464952B2 (en) | 2018-05-03 | 2019-05-03 | Treatment for hydrocephalus |
Country Status (5)
Country | Link |
---|---|
US (2) | US11464952B2 (en) |
EP (1) | EP3773221A4 (en) |
JP (3) | JP2021514801A (en) |
CN (2) | CN112399827B (en) |
WO (1) | WO2019213613A1 (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5385541A (en) * | 1992-04-24 | 1995-01-31 | Loma Linda University Medical Center | Cerebrospinal fluid shunt capable of minimal invasive revision |
US20090048667A1 (en) * | 2005-11-16 | 2009-02-19 | Tokai University Educational System | Controlled Drug-Release Composition and Drug-Releasable Medical Device |
US20110275912A1 (en) * | 2008-12-04 | 2011-11-10 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems, devices, and methods including implantable devices with anti-microbial properties |
US20110282264A1 (en) * | 2002-03-26 | 2011-11-17 | Medtronic Ps Medical, Inc. | Method of draining cerebrospinal fluid |
US20120130467A1 (en) * | 2009-07-24 | 2012-05-24 | Selden Nathan R | Interfacial stent and method of maintaining patency of surgical fenestrations |
US20180117289A1 (en) * | 2016-10-28 | 2018-05-03 | DePuy Synthes Products, LLC | Implantable Valve Assembly With Extended Lifespan |
US20200030588A1 (en) * | 2016-10-11 | 2020-01-30 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US20230058368A1 (en) * | 2014-10-15 | 2023-02-23 | P&X Medical Nv | Therapeutic applications of artificial cerebrospinal fluid and tools provided therefor |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7037288B2 (en) * | 2002-01-14 | 2006-05-02 | Codman & Shurtleff, Inc. | Anti-block catheter |
EP1386634B1 (en) | 2002-08-02 | 2005-10-19 | Medos SA | Cerebrospinal fluid shunt system incorporating an adjustable resistance valve |
US20040236309A1 (en) | 2003-05-19 | 2004-11-25 | Benson Yang | Mesh ventricular catheter with antithrombogenic coating |
CN2640502Y (en) * | 2003-09-03 | 2004-09-15 | 方臻 | Intracranial puncture drain |
US8110211B2 (en) | 2004-09-22 | 2012-02-07 | Advanced Cardiovascular Systems, Inc. | Medicated coatings for implantable medical devices including polyacrylates |
US7390497B2 (en) * | 2004-10-29 | 2008-06-24 | Advanced Cardiovascular Systems, Inc. | Poly(ester amide) filler blends for modulation of coating properties |
AU2006200951B2 (en) | 2005-03-13 | 2012-01-19 | Integra LifeSciences Switzerland Sarl | Pressure sensing devices |
US7700659B2 (en) | 2005-03-24 | 2010-04-20 | Advanced Cardiovascular Systems, Inc. | Implantable devices formed of non-fouling methacrylate or acrylate polymers |
CN1895694A (en) * | 2005-04-05 | 2007-01-17 | 科德曼及舒特莱夫公司 | Subarachnoid epidural shunt |
CN101435430A (en) | 2007-12-19 | 2009-05-20 | 万心悦 | Ceiling fan with automatic cleaning function |
US8088091B2 (en) | 2009-03-09 | 2012-01-03 | New Jersey Institute Of Technology | No clog shunt using a compact fluid drag path |
WO2011146757A2 (en) | 2010-05-21 | 2011-11-24 | Neurodx Development, Llc | Csf shunt flow enhancer, method for generating csf flow in shunts and assessment of partial and complete occlusion of csf shunt systems |
WO2011158244A2 (en) * | 2010-06-18 | 2011-12-22 | Technion Research & Development Foundation Ltd. | Self cleaning shunt |
US20130310767A1 (en) * | 2010-11-16 | 2013-11-21 | C2C Developement, LLC | Seal tip catheter devices or methods |
CN202191577U (en) | 2011-08-22 | 2012-04-18 | 孔建新 | Degradable blockage-proof cerebral ventricular shunt tube for treating hydrocephalus |
CN102319474B (en) | 2011-08-22 | 2013-05-22 | 孔建新 | Degradable anti-blockage ventricle flow division tube for treating hydrocephalus |
WO2013116529A1 (en) * | 2012-01-31 | 2013-08-08 | The Trustees Of Columbia University In The City Of New York | Sampling catheter devices, methods, and systems |
CN202569012U (en) * | 2012-05-24 | 2012-12-05 | 陈有元 | Ventricular shunt tube |
WO2014089028A1 (en) * | 2012-12-04 | 2014-06-12 | Endoclear Llc | Suction cleaning devices, systems and methods |
EP2934614B1 (en) | 2012-12-20 | 2021-03-17 | DSM IP Assets B.V. | Coating comprising polyesteramide copolymers for drug delivery |
EP3679977B1 (en) * | 2014-04-18 | 2023-09-06 | Anuncia Medical, Inc. | Systems for shunting fluid |
CN104014069B (en) | 2014-06-04 | 2016-03-30 | 葛建伟 | A kind of visual ventricles of the brain and Subdural space external drainage system |
CN106924826A (en) * | 2015-12-31 | 2017-07-07 | 重庆润泽医药有限公司 | A kind of brainpan drainage system |
CN205411171U (en) | 2016-03-24 | 2016-08-03 | 石磊 | Ventricles of brain pipe probe of improvement |
US10010392B1 (en) * | 2017-09-06 | 2018-07-03 | Stanislaw L Zukowski | Indwelling valve actuated urinary catheter |
US20210038861A1 (en) * | 2018-02-02 | 2021-02-11 | Microbot Medical Ltd. | Self-cleaning catheter systems with self-monitoring capabilities |
-
2019
- 2019-05-03 EP EP19795875.4A patent/EP3773221A4/en active Pending
- 2019-05-03 CN CN201980045046.6A patent/CN112399827B/en active Active
- 2019-05-03 JP JP2020561700A patent/JP2021514801A/en active Pending
- 2019-05-03 US US16/403,360 patent/US11464952B2/en active Active
- 2019-05-03 WO PCT/US2019/030726 patent/WO2019213613A1/en unknown
- 2019-05-03 CN CN202211126404.6A patent/CN115414583A/en active Pending
-
2022
- 2022-03-01 JP JP2022030746A patent/JP7381628B2/en active Active
- 2022-09-27 US US17/935,882 patent/US20230017481A1/en active Pending
-
2023
- 2023-11-02 JP JP2023188306A patent/JP2024016162A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5385541A (en) * | 1992-04-24 | 1995-01-31 | Loma Linda University Medical Center | Cerebrospinal fluid shunt capable of minimal invasive revision |
US20110282264A1 (en) * | 2002-03-26 | 2011-11-17 | Medtronic Ps Medical, Inc. | Method of draining cerebrospinal fluid |
US20090048667A1 (en) * | 2005-11-16 | 2009-02-19 | Tokai University Educational System | Controlled Drug-Release Composition and Drug-Releasable Medical Device |
US20110275912A1 (en) * | 2008-12-04 | 2011-11-10 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems, devices, and methods including implantable devices with anti-microbial properties |
US20120130467A1 (en) * | 2009-07-24 | 2012-05-24 | Selden Nathan R | Interfacial stent and method of maintaining patency of surgical fenestrations |
US20230058368A1 (en) * | 2014-10-15 | 2023-02-23 | P&X Medical Nv | Therapeutic applications of artificial cerebrospinal fluid and tools provided therefor |
US20200030588A1 (en) * | 2016-10-11 | 2020-01-30 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US20180117289A1 (en) * | 2016-10-28 | 2018-05-03 | DePuy Synthes Products, LLC | Implantable Valve Assembly With Extended Lifespan |
Also Published As
Publication number | Publication date |
---|---|
CN112399827B (en) | 2022-10-18 |
JP7381628B2 (en) | 2023-11-15 |
JP2021514801A (en) | 2021-06-17 |
JP2022088375A (en) | 2022-06-14 |
US11464952B2 (en) | 2022-10-11 |
JP2024016162A (en) | 2024-02-06 |
CN112399827A (en) | 2021-02-23 |
CN115414583A (en) | 2022-12-02 |
EP3773221A4 (en) | 2021-09-15 |
EP3773221A1 (en) | 2021-02-17 |
WO2019213613A1 (en) | 2019-11-07 |
US20190336735A1 (en) | 2019-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11247030B2 (en) | Body fluid drainage system | |
US20180028794A1 (en) | Drainage systems for excess body fluids and associated methods | |
US7189221B2 (en) | Methods for the treatment of a normal pressure hydrocephalus | |
US9042974B2 (en) | Apparatus and method for monitoring and treatment of brain disorders | |
US10413710B2 (en) | Pressure reference assemblies for body fluid drainage systems and associated methods | |
JP5172101B2 (en) | Pressure sensitive instrument | |
US20130303971A1 (en) | Catheter and shunt system including the catheter | |
WO2014043650A2 (en) | Systems, devices and methods for urine monitoring | |
US20170136221A1 (en) | Catheter and shunt system including the catheter | |
WO2015157320A1 (en) | Implantable self-calibrating sensor assemblies and associated methods | |
US9168363B2 (en) | Implantable device for the treatment of hydrocephalus syndrome and the corresponding method | |
KR20210084524A (en) | Self-Adjusting Hydrocephalus Valve | |
US20230017481A1 (en) | Treatment For Hydrocephalus | |
US20080097277A1 (en) | Controllable Shunt |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |